International Clinical Trial: Artemisia Annua Infusion for the Treatment of Asymptomatic Plasmodium Falciparum Infection

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07819825) titled 'Artemisia Annua Infusion for the Treatment of Asymptomatic Plasmodium Falciparum Infection' on Sept. 9.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Centre de Recherche Medicale de Lambarene

Condition: Asymptomatic P.Falciparum Malaria

Intervention: Drug: Artemisia Annua Leaf

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: September 1, 2026

Target Sample Size: 20

Countries of Recruitment: Gabon

To know more, visit https://clinicaltrials.gov/...